Tag: Lifesciences
Zydus plans to launch innovative Semaglutide Injection in India on Day...
The company has developed an innovative Semaglutide Injection (15 mg/3 ml) in a prefilled cartridge administered using a patient-friendly reusable pen for which the company has exclusive rights
Pharma & lifesciences GCCs cut drug timelines by 1–2 years and...
The report by KPMG in India and UnearthIQ was released at BioAsia 2026 in Hyderabad, Asia’s premier life sciences and health-tech forum held on February 17–18
Zydus launches PEPAIR, a first in India, affordable, drug-free, handheld device...
In a patient-centric approach, Zydus offers PEPAIR at an affordable cost of Rs. 990 per unit
TIQ Queensland delegation strengthens global life sciences collaboration at BioAsia 2026
Queensland returns to India for the third consecutive year, underscoring deepening strategic engagement with India’s life sciences and healthcare ecosystem
Zydus Lifesciences reports strong Q3 and 9M FY26 financial performance
In Q3 FY26, revenue from operations rose 30% year-on-year to ₹68,645 million, while EBITDA grew 31% to ₹18,164 million, with margins improving to 26.5%
Edwards Lifesciences launches India’s most advanced Transcatheter Heart Valve
Next-generation technology delivers unmatched durability and minimally invasive treatment for aortic stenosis patients
Zydus Therapeutics announces positive phase 2b/3 results for Saroglitazar in primary...
EPICS-III trial met primary and key secondary endpoints, with Saroglitazar demonstrating significant efficacy, good tolerability, and paving the way for a planned U.S. regulatory submission in early 2026
Telangana emerges as a global life sciences hub with over Rs...
Hyderabad is currently ranked among the world’s top seven life sciences clusters and remains the only Indian city on the list
Zydus Lifesciences posts 6% revenue growth in Q1 FY26, Net profit...
Strong performance in chronic therapies, robust international growth, and strategic acquisitions bolster the company’s innovation pipeline and global presence
Zydus Medtech and Braile Biomedica of Brazil announce global licensing pact...
The company gets rights to market the innovative Transcatheter Aortic Valve Implantation (TAVI) technology in India, Europe and other select markets